<DOC>
	<DOCNO>NCT01723566</DOCNO>
	<brief_summary>Understanding clinical practice treatment cardiac rhythm disorder world understand clinical outcome treatment cardiac rhythm product real world patient population essential Medtronic able effectively develop new product adjust exist product . In addition Medtronic commit monitor safety product throughout entire life cycle ensure maximum product reliability . The Panorama 2 registry enable Medtronic increase data collection clinical practice Medtronic implantable Cardiac Rhythm Disease Management ( CRDM ) device various region across world product reliability CRDM device .</brief_summary>
	<brief_title>PANORAMA 2 Observational Study</brief_title>
	<detailed_description />
	<mesh_term>Arrhythmias , Cardiac</mesh_term>
	<criteria>Inclusion criterion : Patient 18 year age older ( low age limit dependent local law : specify countryspecific addendum clinical investigational plan , applicable ) Patient Legally Authorized Representative provide sign dated authorization and/or consent per institution local requirement Patient treat commercially available implantable Medtronic CRDM device/ Vitatron device within maximally 30 day enrollment within 3 day prior enrollment Exclusion criterion : â€¢ Patient exclusion criterion per local law ( specify countryspecific addendum clinical investigational plan , applicable )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>